Human Diagnostics

Reproductive Health

Our exploration into molecular diagnostics for reproductive health begins with a focus on women's health. Explore the advantages of early detection of sexually transmitted infections using our PathoScan kits.

Logo

HPV Diagnosis to Screen Cervical Cancer Early

Cervical cancer ranks as the fourth most prevalent cancer in women, with around 604,127 cases and 341,831 deaths globally in 2020. In Indonesia, the mortality rate reached 57% in 2021. As it is caused by high-risk HPV infection, cervical cancer can be prevented through early detection of HPV and vaccination against the virus. We are dedicated to lowering cervical cancer incidence rates. Our product lineup is designed to deliver swift and precise diagnosis, empowering healthcare providers to make informed clinical decisions for their patients.

Simplicity at Its Finest

Powered by Fenrir Mastermix. Packaged in a convenient ReadyMix format. Say goodbye to tedious lab reagent mixing! Our ReadyMix formulation reduces preparation time, minimizes contamination risks, and accelerates PCR processes, ensuring swift and accurate diagnosis.

Products

thumbnail

PathoScan hrHPV

PathoScan hrHPV qPCR Kit utilizes our advanced proprietary Fenrir Mastermix with specific fluorescence probes to accurately detect 14 high-risk HPV and genotype HPV52, HPV16, HPV18  from cervical swab and urine samples in under 35 minutes.
thumbnail

PathoScan hrHPV Lite

PathoScan hrHPV qPCR Kit Lite utilizes our advanced proprietary Fenrir Mastermix with specific fluorescence probes to accurately detect 14 types of high-risk HPV and genotype 2 high-risk HPV (HPV16 and 18) from cervical swab and urine samples in under 35 minutes.

Related Applications

thumbnail

Microbiome

Nusantics began its journey by delving into the significance of the microbiome in skin health. Today, we provide a range of services - from research collaborations to routine testing, aimed at deepening our understanding of the human microbiome.
thumbnail

Respiratory

During the COVID-19 pandemic, our diagnostic kits played a crucial role in helping clinicians and policymakers curb the spread of the virus. Now, Nusantics is committed to enhancing healthcare outcomes for all current and future respiratory pathogens.
Logo

© 2025 PT Riset Nusantara Genetika.

Privacy Policy